 |
Immune globulin intravenous (human) octagam 10% |
|---|---|
| Trade Name | |
| Orphan Indication | Dermatomyositis |
| USA Market Approval | USA |
| USA Designation Date | 2017-04-19 00:00:00 |
| Sponsor | OCTAPHARMA USA, Inc.;121 River Street, 12th Floor;Hoboken, New Jersey, 07030 |
| |
Immune globulin intravenous (human) octagam 10% |
|---|---|
| Trade Name | |
| Orphan Indication | Dermatomyositis |
| USA Market Approval | USA |
| USA Designation Date | 2017-04-19 00:00:00 |
| Sponsor | OCTAPHARMA USA, Inc.;121 River Street, 12th Floor;Hoboken, New Jersey, 07030 |